Thomas Sullivan, April 13, 2016.
For the first time, on June 30, 2016, pharmaceutical companies will be forced to disclose full data on payments made to doctors across Europe. Starting then, all pharmaceutical companies will be required to publish payments they made in the previous year to physicians, nurses, and other healthcare professionals (HCPs), identifying them by name when possible. The rules will also encompass payments made to hospitals and other healthcare organizations (HCOs) across thirty-three European countries.
This move is huge for the industry’s relationship with doctors, and reflects a global move toward greater transparency – for better or for worse – following in the footsteps of countries such as the United States and Australia.
To read the article by Thomas Sullivan